GILD - Gilead Sciences, Inc.

Gilead Sciences, Inc. is a global biopharmaceutical company specializing in the development of innovative medicines to address unmet medical needs. With a focus on serious diseases such as HIV, COVID-19, viral hepatitis, and cancer, Gilead's portfolio includes highly advanced therapies, highlighting their commitment to improving healthcare worldwide. The company's operations span over 35 countries, with headquarters in Foster City, California, facilitating extensive market reach and collaboration across varied healthcare systems.

Gilead's business model centers around research and development (R&D) leading to product commercialization, supported by robust clinical trials and partnerships with other pharmaceutical companies. Their key revenue-generating products include antiretrovirals for HIV and therapies for COVID-19, among others. Through strategic collaborations and a focus on innovation, Gilead aims to continue enhancing its product offerings and expanding its therapeutic impact.